<DOC>
	<DOCNO>NCT00494013</DOCNO>
	<brief_summary>The purpose study examine effectiveness safety insulin lispro protamine suspension ( ILPS ) compare insulin detemir basal insulin therapy adult type 2 diabetes . A gatekeeper strategy employ sequentially test secondary objective .</brief_summary>
	<brief_title>Comparison Two Basal Insulins Patients With Type 2 Diabetes ( IOOY )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>1 . Have type 2 diabetes mellitus least 1 year . 2 . Are least 18 year old . 3 . Have receive oral antihyperglycemic medication ( OAMs ) , without insulin , least 3 month immediately prior study stable dos least 2 follow OAMs 6 week prior Visit 1 , dos define follow : Metformin1500 milligram per day ( mg/day ) ; Sulfonylureas1/2 maximum daily dose , accord local package insert ; Dipeptidyl peptidaseintravenous ( DPPIV ) inhibitor 1/2 maximum daily dose , accord local package insert ; Thiazolidinediones ( TZDs ) 30 mg/day pioglitazone 4 mg/day rosiglitazone . 4 . Have hemoglobin A1c ( HbA1c ) great equal 7.5 % less equal 10.0 % , measure central laboratory Visit 2 . 5 . Body mass index ( BMI ) great equal 25 less equal 45 kilogram per square meter ( kg/m2 ) . Exclusion Criteria 1 . Have use insulin therapy ( outside pregnancy ) time past 2 year , except shortterm treatment acute condition , maximum 4 week . 2 . Have take glucoselowering medication include Inclusion Criterion [ 3 ] ( example , acarbose , miglitol , pramlintide , exenatide , repaglinide , nateglinide ) past 3 month Visit 1 . 3 . Have 1 episode severe hypoglycemia , within 6 month prior entry study , currently diagnose hypoglycemia unawareness . 4 . Have history renal transplantation currently receive renal dialysis creatinine great equal 2.0 milligram per deciliter ( mg/dL ) ( 177 micromoles per liter [ micromol/L ] ) . 5 . Have obvious clinical sign symptom , laboratory evidence , liver disease ( alanine transaminase [ ALT ] , aspartate transaminase [ AST ] great 2 time upper limit reference range , define local laboratory ) albumin value normal reference range , define local laboratory .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>diabetes</keyword>
	<keyword>type 2</keyword>
</DOC>